| 5-FU | 5-fluorouracil |
| mTOR | Mammalian target of rapamycin |
| COX-2 | Cyclooxygenase-2 |
| Bcl-2 | B-cell lymphoma 2 |
| BAD | Bcl-xL/Bcl-2 associated death promoter |
| VEGF | Vascular endothelial growth factor |
| EGFR | Epidermal growth factor receptor |
| TSC1 | Tuberous sclerosis 1 |
| TSC2 | Tuberous sclerosis 2 |
| ERK | Extracellular signal-related kinase |
| NSCLC | Non-small-cell lung cancer |
| SCLC | Small-cell lung cancer |
| DES | Drug-eluting stents |
| IL-1β | Interleukin-1β |
| IL-6 | Interleukin-6 |
| IL-10 | Interleukin-10 |
| TNF-α | Tumor necrosis factor-α |
| CRP | C-reactive protein |
| IκBα | IκB kinase |
| NF-κB | Nuclear factor κB |
| AFP | Alpha-fetoprotein |
| PCNA | Proliferation of cell nuclear antigen |
| GR | Gefitinib resistant |
| HIF | Hypoxia-inducible factor |
| IHC | Immunohistochemical |